At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Axiostat®device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Efficacy of Axiostat® Hemostatic Dressing on Radial Access After Percutaneous Procedure
In Brief
An observational study evaluating Axiostat® for Percutaneous Coronary Intervention and 2 related conditions. Completed, enrolled 70 participants across 1 site.
Detailed Summary
To evaluate Safety and Efficacy of Axiostat® hemostatic dressing in terms of time to achieve hemostasis, post application complication and comfort levels of patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPercutaneous Coronary Intervention, Angiography, Angioplasty
CountriesIndia
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 2016
Enrollment StartSep 2016
Primary CompletionNov 2017
TodayJul 2026
First PostedJul 20, 2016
Enrollment StartSep 1, 2016
Primary CompletionNov 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.0 years ago
Interventions
Axiostat®device
Axiostat Chitosan Hemostatic dressing belongs to an advanced class of wound dressing that stops bleeding within few minutes of application by providing an active mechanical barrier.